These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Involvement of striatum serotonergic system in the expression of genetically defined catalepsy. Popova NK, Kulikov AV, Avgustinovich DF, Barykina NN. Ross Fiziol Zh Im I M Sechenova; 1997 Dec; 83(5-6):66-79. PubMed ID: 13677667 [Abstract] [Full Text] [Related]
3. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists. Millan MJ, Canton H, Gobert A, Lejeune F, Rivet JM, Bervoets K, Brocco M, Widdowson P, Mennini T, Audinot V. J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575 [Abstract] [Full Text] [Related]
14. 5-HT1A receptor-mediated G protein activation assessed by [35S]GTPgammaS binding in rat cerebral cortex. Odagaki Y, Toyoshima R. Eur J Pharmacol; 2005 Oct 03; 521(1-3):49-58. PubMed ID: 16182280 [Abstract] [Full Text] [Related]
16. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine. Jolas T, Haj-Dahmane S, Kidd EJ, Langlois X, Lanfumey L, Fattaccini CM, Vantalon V, Laporte AM, Adrien J, Gozlan H. J Pharmacol Exp Ther; 1994 Mar 03; 268(3):1432-43. PubMed ID: 8138956 [Abstract] [Full Text] [Related]
17. Orally active benzamide antipsychotic agents with affinity for dopamine D2, serotonin 5-HT1A, and adrenergic alpha1 receptors. Reitz AB, Baxter EW, Codd EE, Davis CB, Jordan AD, Maryanoff BE, Maryanoff CA, McDonnell ME, Powell ET, Renzi MJ, Schott MR, Scott MK, Shank RP, Vaught JL. J Med Chem; 1998 Jun 04; 41(12):1997-2009. PubMed ID: 9622541 [Abstract] [Full Text] [Related]